St. Jude Medical (STJ) Tops Q1 EPS by 3c; Guides Q2, FY12
Tweet
Share
E-mailGet Alerts STJ Hot Sheet
Price: $80.82 --0%
Financial Fact:
Research and development expense: 183M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development expense: 183M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
St. Jude Medical, Inc. (NYSE: STJ) reported Q1 EPS of $0.86, $0.03 better than the analyst estimate of $0.83. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.38 billion.
Sees Q2 2012 EPS of $0.86-$0.88, versus the consensus of $0.89.
St. Jude Medical, Inc. sees FY2012 EPS of $3.44-$3.49, versus the consensus of $3.46.
For earnings history and earnings-related data on St. Jude Medical, Inc. (STJ) click here.
Sees Q2 2012 EPS of $0.86-$0.88, versus the consensus of $0.89.
St. Jude Medical, Inc. sees FY2012 EPS of $3.44-$3.49, versus the consensus of $3.46.
For earnings history and earnings-related data on St. Jude Medical, Inc. (STJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- UBS says bull market has further to run
- Is the global equity rally broadening? UBS weighs in
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
